Jun 12, 2020
EHA25Virtual: PET-guided Therapy Allows Omission of Radiotherapy in Early-stage Unfavorable Hodgkin Lymphoma
Apr 17, 2020
CAR T-Cell Therapy for Non-Hodgkin's Lymphoma | US & EU Market Sizes from 2017 to 2030, Details of Marketed & Emerging Therapies Kymriah (Novartis) & KTE-X19 (Gilead Sciences)
Feb 27, 2020
Hodgkin Lymphoma Treatment Market Forecasts to 2025 with Alkem Labs, Amneal Pharma, Baxter Int'l, Biogen, BMS, Roche, Incyte Corp, Merck & Co, Seattle Genetics, and Teva Pharma Industries Dominating
Feb 27, 2020
Tessa Therapeutics Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to its CD30 CAR-T Cell Therapy for the Treatment of Relapsed or Refractory CD30-positive Classical Hodgkin Lymphoma
Jan 27, 2020
Global B-cell Non-Hodgkin's Lymphoma Market Review 2017-2019 and Forecast 2020-2028
Dec 08, 2019
Viracta Announces Positive Phase 1b/2 Data Presented at Oral Presentation on Lead Program for Epstein-Barr Virus (EBV)-associated Relapsed/Refractory Lymphomas at the 2019 American Society of Hematology (ASH) Annual Meeting
Nov 27, 2019
Global non-hodgkin lymphoma treatment market. to grow with a CAGR of 7.2% over the forecast period from 2019-2025
Nov 06, 2019
Viracta Announces Oral Presentation on Lead Program for EBV-associated Lymphomas at the 2019 American Society of Hematology (ASH) Annual Meeting
Aug 11, 2019
A New Model for Lymphoma Drug Discovery
Jul 11, 2019
Nordic Nanovector Completes Patient Enrolment Into Phase 1 Trial of Betalutin® in Diffuse Large B-cell Lymphoma (DLBCL)
Jul 11, 2019
Non-Hodgkin Lymphoma (NHL) Therapeutics Market to Record a CAGR of 7.4% During 2019-2024
Jun 27, 2019
Silicon Valley Companies Raise Money for The Leukemia & Lymphoma Society
Jun 11, 2019
Global Non-Hodgkin Lymphoma Clinical Trial Pipeline Report 2019-2024: Clinical Trial Stages, Drug Mechanism Classes, Company, & Short-Term Launch Highlights
Jun 03, 2019
Nordic Nanovector: European Patent Granted for Betalutin® or Humalutin® in Combination With Anti-CD20 Antibodies for Treating NHL
Apr 17, 2019
Global Hodgkin's Lymphoma Drugs Market 2019-2023: Treatment of Hodgkin's Lymphoma Patients with Conjoint Conditions Gaining Momentum
Apr 10, 2019
Nordic Nanovector: Safety Review Committee Approves Advancing to Final Dosing Regimen in Phase 1 Trial of Betalutin® in DLBCL
Mar 21, 2019
The AM Charity Fund Introduces Their First Theater Show "The Evolution of Dance" to Raise Money for LLS Says 360Wise Media
Mar 20, 2019
Lymphoma Research Foundation Announces More Than 20 Lymphoma and Chronic Lymphocytic Leukemia Research Grants
Mar 12, 2019
The hodgkin's lymphoma drugs market will register a CAGR of close to 16% by 2023
Jan 30, 2019
BioInvent Receives FDA Orphan Designation for BI-1206 for Mantle Cell Lymphoma